Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nuvation Bio Inc shares valued at $1,173,255 were sold by Liu Dongfang on Dec 01 ’25. At $7.82 per share, Liu Dongfang sold 150,000 shares. The insider’s holdings dropped to 18,000 shares worth approximately $0.15 million following the completion of this transaction.
Also, DONGFANG LIU purchased 150,000 shares, netting a total of over 1,173,255 in proceeds.
Before that, Liu Dongfang had sold 10,000 shares from its account. In a trade valued at $80,000, the CHIEF MEDICAL OFFICER traded Nuvation Bio Inc shares for $8.00 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $0.15 million.
As published in their initiating research note from Truist on November 24, 2025, Nuvation Bio Inc [NUVB] has been a Buy. Analysts at B. Riley Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in mid November. As of September 30, 2025, Jefferies has initiated its “Buy” rating for NUVB. Earlier on April 23, 2025, Citizens JMP initiated its rating. Their recommendation was “a Mkt outperform” for NUVB stock.
Analyzing NUVB Stock Performance
On last trading session, Nuvation Bio Inc [NYSE: NUVB] plunged -4.41% to $8.45. The stock’s lowest price that day was $8.35, but it reached a high of $8.8644 in the same session. During the last five days, there has been a drop of approximately -5.69%. Over the course of the year, Nuvation Bio Inc shares have jumped approximately 197.54%. Shares of the company reached a 52-week high of $9.10 on 01/07/26 and a 52-week low of $8.03 on 01/05/26.
Support And Resistance Levels for Nuvation Bio Inc (NUVB)
According to the 24-hour chart, there is a support level at 8.25, which, if violated, would cause prices to drop to 8.04. In the upper region, resistance lies at 8.76. The next price resistance is at 9.07. RSI (Relative Strength Index) is 51.45 on the 14-day chart, showing neutral technical sentiment.
Is Nuvation Bio Inc subject to short interest?
Stocks of Nuvation Bio Inc saw a sharp steep in short interest on 2025-12-15 dropping by -20.37 million shares to 45.98 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 66.35 million shares. A decline of -44.31% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.61 of the overall float, the days-to-cover ratio (short ratio) decline to 4.61.
Which companies own the most shares of Nuvation Bio Inc (NUVB)?
In terms of Nuvation Bio Inc share price expectations, FactSet research, analysts set an average price target of 10.5 in the next 12 months, up nearly 18.78% from the previous closing price of $8.84. Analysts anticipate Nuvation Bio Inc stock to reach 18 by 2026, with the lowest price target being 10. In spite of this, 4 analysts ranked Nuvation Bio Inc stock as Buy at the end of 2026. On March 27, 2024, Jefferies assigned a price target of “a Buy” to the stock and upgraded coverage with a $10.
